Malignant neoplasm of ventral surface of tongue
ICD-10 C02.2 is a billable code used to indicate a diagnosis of malignant neoplasm of ventral surface of tongue.
C02.2 refers to a malignant neoplasm located on the ventral surface of the tongue, which is the underside of the tongue. This type of cancer is often squamous cell carcinoma, which is the most common form of oral cancer. The ventral surface of the tongue is particularly susceptible to carcinogenic factors such as tobacco use, alcohol consumption, and human papillomavirus (HPV) infection. Symptoms may include a persistent sore or ulcer on the tongue, difficulty swallowing, and changes in speech. Diagnosis typically involves a biopsy, imaging studies, and thorough clinical evaluation. Treatment options may include surgical resection, radiation therapy, and chemotherapy, depending on the stage of the cancer. The prognosis varies based on the tumor's size, location, and whether it has metastasized to lymph nodes or other areas. Early detection is crucial for improving outcomes, making awareness of symptoms and risk factors essential for both patients and healthcare providers.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with oral lesions, difficulty swallowing, or unexplained weight loss.
Ensure accurate staging and grading of the tumor to guide treatment decisions.
Comprehensive examination findings, including endoscopic evaluations and biopsy results.
Patients with persistent sore throat, hoarseness, or lesions on the tongue.
Document any surgical interventions and post-operative care thoroughly.
Used when a malignant neoplasm is surgically excised.
Document the size, location, and type of tumor excised.
Oncologists and otolaryngologists should ensure accurate coding of the excision site.
Common symptoms include persistent sores or ulcers, difficulty swallowing, changes in speech, and unexplained weight loss.
Diagnosis typically involves a clinical examination, imaging studies, and a biopsy to confirm malignancy.
Treatment options may include surgical resection, radiation therapy, and chemotherapy, depending on the stage of the cancer.
